Aim The aim of this study was to assess the association between the third component of the
complement (C3) and other risk factors of coronary heart disease. Methods and results We …

Aims/hypothesis Mice that are deficient for complement factor 3 (C3) have shown resistance
to weight gain, despite increased food intake. Cross-sectional studies of humans have …

OBJECTIVE: Chronic inflammation plays a role in the pathogenesis of metabolic syndrome
(MetS) and cardiovascular disease (CVD). Complement component 3 (C3) is a novel …

Background Chronic inflammation is characteristic of type 2 diabetes mellitus (T2DM).
Obesity‐activated adipocytes release adipocytokines, which induce the secretion of …

The aim of this study was to explore the association between the serum concentration of
complement component 3 (C3) and a variety of metabolic parameters. The study involved …

Plasma concentrations of the third complement component (C3) predict the risk of
myocardial infarction. Because chylomicrons stimulate C3 production by adipocytes in vitro …

Cross-sectional studies have reported strong correlations between plasma levels of
complement C3, insulin, and glucose. This prospective study explored whether elevated …

OBJECTIVE—This study was performed to ascertain the relative relevance of some
inflammatory markers in insulin resistance. RESEARCH DESIGN AND METHODS—Four …

Objective: To analyze the relationship between complement component 3 (C3) and the
prevalence of cardiometabolic risk factors and disease activity in the rheumatic diseases …

OBJECTIVE To test the hypothesis that the complement system may be activated in patients
with type II diabetes and CAD. RESEARCH DESIGN AND METHODS The plasma C3d …